Yutaka Tokuda Selected Research

Yutaka Tokuda Research Topics

Disease

76	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2002
52	Neoplasms (Cancer) 09/2020 - 01/2002
13	Neoplasm Metastasis (Metastasis) 07/2016 - 01/2004
5	Pain (Aches) 07/2016 - 10/2005
4	Disease Progression 01/2018 - 08/2003
4	Neutropenia 05/2017 - 10/2003
3	Brain Neoplasms (Brain Tumor) 11/2017 - 08/2014
3	Cardiotoxicity 11/2015 - 04/2002
3	Anemia 11/2014 - 10/2003
2	Triple Negative Breast Neoplasms 10/2019 - 12/2007
2	Nausea 02/2019 - 09/2009
2	Vomiting 02/2019 - 09/2009
2	Lymphatic Metastasis 12/2017 - 07/2005
2	Febrile Neutropenia 04/2015 - 09/2013
2	Stomatitis 01/2015 - 11/2014
2	Dyspnea (Shortness of Breath) 11/2014 - 05/2011
2	Carcinoma (Carcinomatosis) 05/2014 - 09/2013
2	Drug-Related Side Effects and Adverse Reactions 09/2013 - 09/2011
2	Abdominal Pain (Pain, Abdominal) 02/2011 - 09/2010
2	Thrombocytopenia (Thrombopenia) 09/2009 - 10/2003
2	Fatigue 09/2009 - 10/2003
1	Weight Loss (Weight Reduction) 09/2020
1	Malnutrition (Nutritional Deficiencies) 09/2020
1	Communicable Diseases (Infectious Diseases) 12/2019
1	Surgical Wound 09/2017
1	Pyoderma Gangrenosum 09/2017
1	Abscess 09/2017
1	Rheumatoid Arthritis 07/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017

Drug/Important Bio-Agent (IBA)

19	Trastuzumab (Herceptin)FDA Link 01/2018 - 04/2002
17	Hormones (Hormone)IBA 10/2023 - 03/2003
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2021 - 07/2002
10	human ERBB2 proteinIBA 01/2021 - 10/2003
9	AnthracyclinesIBA 10/2019 - 04/2002
7	Docetaxel (Taxotere)FDA Link 10/2019 - 01/2004
7	ErbB Receptors (EGF Receptor)IBA 01/2018 - 08/2005
7	Estrogen ReceptorsIBA 04/2016 - 08/2005
6	Epirubicin (Ellence)FDA LinkGeneric 09/2020 - 07/2002
6	Monoclonal AntibodiesIBA 11/2015 - 04/2002
6	Proteins (Proteins, Gene)FDA Link 12/2013 - 03/2002
6	taxaneIBA 08/2013 - 10/2003
5	Fluorouracil (Carac)FDA LinkGeneric 02/2021 - 03/2009
4	Phenobarbital (Luminal)FDA Link 02/2021 - 08/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 06/2006
4	Epidermal Growth Factor (EGF)IBA 04/2017 - 08/2005
4	Biomarkers (Surrogate Marker)IBA 12/2013 - 04/2011
4	Taxoids (Taxanes)IBA 10/2012 - 07/2002
3	Methotrexate (Mexate)FDA LinkGeneric 02/2021 - 03/2009
3	Peptides (Polypeptides)IBA 01/2021 - 10/2011
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2015 - 06/2007
3	Vinorelbine (Navelbine)FDA LinkGeneric 08/2006 - 10/2003
2	TegafurIBA 02/2021 - 03/2009
2	UracilIBA 02/2021 - 03/2009
2	Immune Checkpoint InhibitorsIBA 12/2019 - 11/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2018 - 09/2014
2	AntibodiesIBA 11/2017 - 12/2016
2	Tumor Biomarkers (Tumor Markers)IBA 07/2016 - 07/2012
2	Alkaline PhosphataseIBA 07/2016 - 09/2009
2	pegfilgrastim (Neulasta)FDA Link 10/2015 - 04/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2015 - 07/2002
2	Filgrastim (Neupogen)FDA Link 04/2015 - 09/2013
2	exemestane (Aromasin)FDA Link 01/2015 - 11/2014
2	Aromatase InhibitorsIBA 01/2015 - 11/2014
2	Everolimus FDA Link 01/2015 - 11/2014
2	EnzymesIBA 11/2014 - 03/2004
2	Keratins (Keratin)IBA 05/2014 - 09/2013
2	Alanine Transaminase (SGPT)IBA 04/2014 - 09/2013
2	Tyrosine Kinase InhibitorsIBA 01/2014 - 08/2013
2	orantinib (SU6668)IBA 01/2014 - 08/2013
2	Indicators and Reagents (Reagents)IBA 01/2014 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 07/2005
2	Messenger RNA (mRNA)IBA 08/2013 - 08/2012
2	Gemcitabine FDA Link 10/2012 - 11/2009
2	Lapatinib (GW572016)FDA Link 06/2011 - 12/2010
2	Fentanyl (Sublimaze)FDA LinkGeneric 02/2011 - 09/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2010 - 12/2007
2	Antineoplastic Agents (Antineoplastics)IBA 06/2006 - 10/2003
1	eribulin FDA Link 10/2023
1	netupitantIBA 02/2019
1	Palonosetron (Aloxi)FDA Link 02/2019
1	Neurokinin-1 Receptor AntagonistsIBA 02/2019
1	NK105IBA 01/2019
1	Antirheumatic Agents (DMARD)IBA 07/2017
1	130-nm albumin-bound paclitaxelIBA 05/2017
1	Albumin-Bound Paclitaxel FDA Link 05/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	AntigensIBA 01/2017
1	LigandsIBA 12/2016
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 09/2016

Therapy/Procedure

36	Therapeutics 10/2023 - 03/2002
23	Drug Therapy (Chemotherapy) 09/2020 - 06/2003
4	Adjuvant Chemotherapy 07/2022 - 03/2009
4	Neoadjuvant Therapy 12/2020 - 04/2011
3	Radiotherapy 12/2019 - 04/2010
3	Mastectomy (Mammectomy) 08/2019 - 07/2017
3	Segmental Mastectomy (Lumpectomy) 09/2017 - 04/2010
3	Aftercare (After-Treatment) 10/2012 - 10/2003
3	Palliative Care (Palliative Therapy) 05/2011 - 12/2009
2	Molecular Targeted Therapy 01/2011 - 04/2010
1	Sutures (Suture) 09/2017